Jagged-2, a signaling protein, may be a potential therapeutic target for slowing or halting the progression of PAH, according ...
Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback